RITEPOD 50 D.SYP+ WFS
— Product

RITEPOD 50 D.SYP+ WFS

CEFPODOXIME 50MG SYP

RITEPOD 50 D.SYP+ WFS is a dry syrup of cefpodoxime 50 mg, a third-generation oral cephalosporin, reconstituted before use. It is a paediatric preparation for otitis media, pharyngitis, tonsillitis, sinusitis, pneumonia and skin infections, dosed by body weight.

01

Benefits

  • Broader Gram-positive cover than cefixime, useful in childhood ear, throat and skin infection.
  • Twice-daily dosing is manageable for children and their carers.
  • The liquid form allows accurate weight-based dosing.
  • The dry syrup format keeps the antibiotic stable until reconstitution.
  • A practical oral step-down after initial injectable therapy.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Diarrhoea or loose stools
  • Nausea or vomiting
  • Abdominal discomfort
  • Skin rash
Less common
  • Oral or nappy-area thrush after the course
  • Raised liver enzymes on testing
  • Irritability or disturbed sleep
  • Bitter aftertaste
Stop and get medical help if any of these occur
  • Swelling of the face, lips or tongue, difficulty breathing, or collapse
  • Severe, watery or bloody diarrhoea during or in the weeks after the course
  • Widespread rash with blistering or peeling skin
  • Yellowing of the skin or eyes
  • Persistent vomiting, or signs of dehydration
03

Precautions

  • Contraindicated in known cephalosporin allergy; use with caution in penicillin allergy and avoid after penicillin anaphylaxis.
  • Give with food. Cefpodoxime absorption requires gastric acid, and avoiding antacids around the dose matters.
  • Reconstitute exactly to the mark, shake well before every dose, and use the measure supplied.
  • Store as directed after reconstitution and discard after the stated period.
  • Dose strictly by body weight on the prescriber's instruction.
  • Dose reduction is required in significant renal impairment.
  • Complete the full prescribed course; never keep a part-used bottle for a future illness.